BASF weighs higher Evonik offer: BASF stock sits 5.10 percent below its high

Published on 10/15/2026 at 10:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 16.00 percent to EUR 17.20 billion in the second quarter. BASF stock costs EUR 52.24 on October 15, 2026, below the Xetra close.

Evonik offer and key dates

BASF kept a higher Evonik offer open on October 14, 2026 after an initial EUR 22.15 bid.
Second-quarter revenue rose 16.00 percent to EUR 17.20 billion in 2026.
BASF stock trades at EUR 52.24 at 10:45 a.m. CEST at Lang & Schwarz on October 15, 2026, 0.42 percent below the Xetra close of October 14, 2026.
Bernstein maintained a Buy rating and set a EUR 61.00 target on October 14, 2026.
BASF will publish third-quarter results on October 28, 2026.

Reagenzglas auf Börsenpult vor Handelsraum-Monitoren mit DAX-Chart und grünen Kursanzeigen — Redaktionelles Finanzfoto: Im Hintergrund ein lebhafter Handelsraum mit gewölbten Monitorwänden, DAX-Beschriftung und grünen Candlestick-Charts. Im Vordergrund scharf fokussiert auf einem dunklen Hochglanzpult ein einzelnes klares Glasreagenzglas mit bernsteinfarbener Flüssigkeit in einem Metallständer. Geringe Schärfentiefe lässt die Bildschirme zu farbigem Bokeh verschwimmen, Illustration mit AI erstellt.

BASF (ISIN DE000BASF111) was trading at EUR 52.24 at Lang & Schwarz on October 15, 2026 at 10:45 a.m. CEST, down 0.42 percent versus the Xetra close of October 14, 2026 at EUR 52.46. According to WirtschaftsWoche on October 14, 2026, BASF kept a higher offer for Evonik open after an initial bid of EUR 22.15 per share was rejected.

What does the deal mean for BASF?

The proposal remains exploratory rather than a completed transaction. WirtschaftsWoche reported that BASF would first seek access to Evonik's books before considering another offer, while the initial approach valued Evonik at more than EUR 14.0 billion including debt.

The strategic question comes as BASF enters its next reporting checkpoint. EQS News reported on July 15, 2026 that second-quarter revenue rose 16.00 percent year over year to EUR 17.20 billion. Adjusted EBITDA reached EUR 2.40 billion, above the EUR 2.10 billion analyst consensus, while BASF lifted its full-year adjusted EBITDA outlook to EUR 6.90 billion to EUR 7.70 billion.

Three dates frame the story

BASF reported on July 15, 2026 that stronger prices and volumes supported second-quarter revenue. On September 25, 2026, BASF confirmed exploratory work on a possible Evonik acquisition. On October 14, 2026, WirtschaftsWoche reported that BASF was open to a higher offer after the EUR 22.15 approach.

What dates come next?

BASF's next reporting date is October 28, 2026, when the company will publish its third-quarter figures and hold an analyst and investor conference. The Capital Markets Day is scheduled for November 23 and November 24, 2026.

Bernstein maintained a Buy rating and set a EUR 61.00 price target on October 14, 2026, according to Markets Insider. Against the Lang & Schwarz price, that target is 16.75 percent above the price, although the potential Evonik purchase adds execution and financing questions.

Stock stays below the yearly high

BASF stock was 5.10 percent below its 52-week high of EUR 55.05 on October 15, 2026. The company's market capitalization was EUR 45.1 billion, and the stock belongs to the DAX.

The further course of trading is shown by the continuously updated real-time quote of BASF stock.